You are here

  • Home
  • Archive
  • Volume 74, Issue 3
  • A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C

Citation Tools

Article menu
Download PDFPDF
Letters
A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chen Y, Chen H, Chen Y, et al
A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C
Annals of the Rheumatic Diseases 2015;74:626-627.